Great success of ABIVAX IPO on Euronext Paris, with €57.7 million raised

 

  • Full exercise of the extension clause and of the overallotment option
  • Share price set at €21.30 - mid-point of the price range
  • Market capitalization of €205 million on a non-diluted basis

Press contacts

Caroline Carmagnol 

abivax@alizerp.com

+ 33 6 64 18 99 59 or
+ 33 1 44 54 36 65

 Standard: +33 1 53 83 08 41